Unknown

Dataset Information

0

Pattern Recognition of the Multiple Sclerosis Syndrome.


ABSTRACT: During recent decades, the autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), once broadly classified under the umbrella of multiple sclerosis (MS), has been extended to include autoimmune inflammatory conditions of the central nervous system (CNS), which are now diagnosable with serum serological tests. These antibody-mediated inflammatory diseases of the CNS share a clinical presentation to MS. A number of practical learning points emerge in this review, which is geared toward the pattern recognition of optic neuritis, transverse myelitis, brainstem/cerebellar and hemispheric tumefactive demyelinating lesion (TDL)-associated MS, aquaporin-4-antibody and myelin oligodendrocyte glycoprotein (MOG)-antibody NMOSD, overlap syndrome, and some yet-to-be-defined/classified demyelinating disease, all unspecifically labeled under MSsyndrome. The goal of this review is to increase clinicians' awareness of the clinical nuances of the autoimmune conditions for MS and NMSOD, and to highlight highly suggestive patterns of clinical, paraclinical or imaging presentations in order to improve differentiation. With overlay in clinical manifestations between MS and NMOSD, magnetic resonance imaging (MRI) of the brain, orbits and spinal cord, serology, and most importantly, high index of suspicion based on pattern recognition, will help lead to the final diagnosis.

SUBMITTER: Zabad RK 

PROVIDER: S-EPMC5664065 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pattern Recognition of the Multiple Sclerosis Syndrome.

Zabad Rana K RK   Stewart Renee R   Healey Kathleen M KM  

Brain sciences 20171024 10


During recent decades, the autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), once broadly classified under the umbrella of multiple sclerosis (MS), has been extended to include autoimmune inflammatory conditions of the central nervous system (CNS), which are now diagnosable with serum serological tests. These antibody-mediated inflammatory diseases of the CNS share a clinical presentation to MS. A number of practical learning points emerge in this review, which is geared toward  ...[more]

Similar Datasets

| S-EPMC3117878 | biostudies-literature
2016-07-03 | E-GEOD-60943 | biostudies-arrayexpress
2016-01-01 | GSE60943 | GEO
| PRJNA259871 | ENA
| S-EPMC4908696 | biostudies-other
| S-EPMC5561305 | biostudies-other
| PRJEB65098 | ENA
| S-EPMC7830121 | biostudies-literature
| S-EPMC10984715 | biostudies-literature
| S-EPMC4574806 | biostudies-other